FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Watch: ‘The View’ Hit Its Lowest Low Ever as Joy Behar Attacks ‘Narcissistic’ Jesus in Blasphemous On-Air Rant

Trump taps former deputy surgeon general to helm CDC

Ketanji Brown Jackson Publicly Attacks Her Supreme Court Colleagues for ‘Utterly Irrational’ Decisions

Scamming the West: What’s really behind the UN’s ahistorical transatlantic slavery resolution

Israel and Lebanon take a critical step forward on the road to peace

The un-shock effects of ‘Undertone’

Greenland talks on ‘good trajectory,’ White House says amid Trump takeover push

House punts Trump spy powers extension after conservatives block deal, forcing end-of-month showdown

Trump admin announces expansion of visa restriction policy in Western Hemisphere

Singer D4vd arrested and held without bail in case tied to teen found dead in Tesla: Police

EXCLUSIVE: NYC officials refuse ICE hold for illegal alien accused in arson that killed 4 and injured 7: DHS

Ex-teacher faces 25 charges, including rape and abuse as investigation widens

Jerome Powell Now Considering Move to Spite Trump: Report

Missing pregnant woman found dead after mysterious Texas disappearance

Franklin Graham defends Trump in letter shared on Truth Social after AI ‘Jesus’ image backlash

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”